![Stuart Gunzburg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Gunzburg
Teknisk/Vetenskaplig/F&U Direktör på
EVE HEALTH GROUP LIMITED
Förmögenhet: 275 931 $ per 2026-08-31
Profil
Stuart Gunzburg is the founder of Nextract Pty Ltd. Dr. Gunzburg is currently Managing Director & Director at Metavone Ltd. Dr. Gunzburg is also Executive Director & Chief Scientific Officer at EVE Health Group Ltd., starting in 2025.
Dr. Gunzburg holds an MBA and a doctorate from The University of Western Australia.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EVE HEALTH GROUP LIMITED 7,81 % | 2026-03-20 | 27 510 581 ( 7,81 % ) | 275 931 $ | 2026-08-31 |
Aktiva positioner av Stuart Gunzburg
| Företag | Position | Start |
|---|---|---|
| EVE HEALTH GROUP LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-12 |
Metavone Ltd.
 Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Verkställande Direktör | - |
Stuart Gunzburgs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
11
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
EVE Health Group Ltd.
 EVE Health Group Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and retails health and wellness food products | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metavone Ltd.
Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers | Health Technology |
